AIM 27 March 2019 NOTICE 27/03/2019 - 7:00am NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM - XLON At the request of the company the...
Realm Therapeutics Announces Cancellation of AIM Listing PR Newswire MALVERN, Pa., March 26, 2019 MALVERN, Pa., March 26, 2019 /PRNewswire/...
Realm Therapeutics PLC 26 March 2019 Realm Therapeutics plc ("Realm", "Realm Therapeutics" or the "Company"...
Realm Therapeutics PLC 25 March 2019 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this...
Realm Therapeutics PLC 25 March 2019 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction...
Nplus1 Singer Capital Markets Ltd 20 March 2019 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED...
Nplus1 Singer Capital Markets Ltd 18 March 2019 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED...
Realm Therapeutics Announces Result of General Meeting All Resolutions Passed Reminder: Process to Convert Ordinary Shares into ADSs PR...
Realm Therapeutics PLC 15 March 2019 Realm Therapeutics plc Result of General Meeting All Resolutions Passed Reminder: Process to Convert Ordinary...
Nplus1 Singer Capital Markets Ltd 15 March 2019 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED...
Nplus1 Singer Capital Markets Ltd 14 March 2019 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED...
Nplus1 Singer Capital Markets Ltd 13 March 2019 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED...
Ali Mortazavi 12 March 2019 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES...
Nplus1 Singer Capital Markets Ltd 12 March 2019 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads